The Simply Good Foods Company Reports Third Quarter Fiscal 2017 Financial Results
Fiscal third quarter 2017 financial results for Atkins reflect the 13 weeks ended
“We are very pleased with our third quarter financial results, which are evidence of the consistent, successful execution of our efforts to increase consumption through distribution and velocity gains as well as the introduction of innovative new products,” commented
Third Quarter Fiscal 2017 Highlights
- Net sales were
$96.5 million - Gross profit was
$43.6 million , representing 45.1% of net sales - Net income was
$4.3 million - Pro Forma Adjusted EBITDA was
$14.8 million , representing 15.3% of net sales
On a GAAP basis, net sales decreased approximately 8% from the 13 weeks ended
Pro Forma Adjusted net sales, which have been adjusted for the change in licensing, increased
Year-to-Date Fiscal 2017 Highlights
- Net sales were
$298.6 million - Gross profit was
$138.9 million , representing 46.5% of net sales - Net income was
$14.6 million - Pro Forma Adjusted EBITDA was
$55.1 million , representing 18.5% of net sales
On a GAAP basis, net sales decreased approximately 8% from the 39 weeks ended
Pro Forma Adjusted net sales, which have been adjusted for the change in licensing, increased approximately
For the full fiscal year of 2017,
Conference Call and Webcast Information
The Company will host a conference call with members of the executive management team to discuss these results today,
In addition, the call and supplementary presentation slides will be broadcast live over the Internet hosted at the “Investor Relations” section of the Company's website at http://www.thesimplygoodfoodscompany.com/. The webcast will be archived for 30 days. A telephone replay will be available approximately two hours after the call concludes and will be available through
About The
The
Forward Looking Statements
Certain statements made herein are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by or include words such as “will”, “believe”, “potential”, “increase”, “continue”, “expect”, “aspires”, “outlook” or the negative or other variations thereof and other similar words, phrases or expressions. These forward-looking statements include statements regarding future plans for the Company, the estimated or anticipated future results and benefits of the Company’s future plans and operations, future opportunities for the Company, and other statements that are not historical facts. These statements are based on the current expectations of the Company’s management and are not predictions of actual performance. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements based on a number of factors, including but not limited to the following: changes in the business environment in which the Company operates including general financial, economic, regulatory and political conditions affecting the industry in which the Company operates; changes in consumer preferences and purchasing habits; the availability of or competition for other brands, assets or other opportunities for investment by the Company or to expand the Company’s business; changes in taxes, governmental laws, and regulations; competitive product and pricing activity; difficulties of managing growth profitably; the loss of one or more members of Company’s management teams; and other risk factors described from time to time in the Company’s Form 10-K, Form 10-Q, and Form 8-K reports (including all amendments to those reports) filed with the U.S. Securities and Exchange Commission from time to time. In addition, forward-looking statements provide the Company’s expectations, plans or forecasts of future events and views as of the date of this communication. Except as required by law, the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date, and cautions investors not to place undue reliance on any such forward-looking statements. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this communication.
Non-GAAP Financial Measure and Related Information
This communication includes Pro Forma Net Sales and Adjusted EBITDA, a financial measure that is not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Atkins defines Adjusted EBITDA as net income (loss) before interest expense, income tax expense, depreciation and amortization with further adjustments to exclude the following items: stock-based compensation and warrant expense, transaction costs and IPO readiness, restructuring costs, management fees, transactional exchange impact and other onetime expenses. Atkins believes that the inclusion of these supplementary adjustments in presenting Adjusted EBITDA are appropriate to provide additional information to investors and reflects more accurately operating results of the on-going operations. Adjusted EBITDA may not be comparable to other similarly titled captions of other companies due to differences in calculation. Atkins management believes that this non-GAAP measure of financial results provides useful information to management and investors regarding certain financial and business trends relating to Atkins’ financial condition and results of operations. You should review the reconciliation of Atkins’ non-GAAP financial measures to the comparable GAAP financial measures which are included in this press release, Form 10-Q and investor presentation to be filed by The
NCP-ATK Holdings, Inc. and Subsidiaries | ||||||||||||||||
(dba Atkins Nutritionals) | ||||||||||||||||
Condensed Consolidated Statements of Operations and Comprehensive Income | ||||||||||||||||
(Unaudited) | ||||||||||||||||
(In thousands, except share data) | ||||||||||||||||
Thirteen Weeks Ended | Thirty-Nine Weeks Ended | |||||||||||||||
May 27, | May 28, | May 27, | May 28, | |||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Net sales | $ | 96,503 | $ | 104,590 | $ | 298,614 | $ | 324,367 | ||||||||
Cost of goods sold | 52,933 | 62,162 | 159,759 | 188,651 | ||||||||||||
Gross profit | 43,570 | 42,428 | 138,855 | 135,716 | ||||||||||||
Operating Expenses: | ||||||||||||||||
Distribution | 4,084 | 4,598 | 13,413 | 13,673 | ||||||||||||
Selling | 4,350 | 5,444 | 12,621 | 14,813 | ||||||||||||
Marketing | 9,733 | 9,494 | 28,969 | 28,958 | ||||||||||||
General and administrative | 12,276 | 12,215 | 33,975 | 34,080 | ||||||||||||
Depreciation and amortization | 2,482 | 2,458 | 7,409 | 7,705 | ||||||||||||
Other Expense | 17 | 227 | 75 | 652 | ||||||||||||
Total operating expenses | 32,942 | 34,436 | 96,462 | 99,881 | ||||||||||||
Income from operations | 10,628 | 7,992 | 42,393 | 35,835 | ||||||||||||
Other income (expense): | ||||||||||||||||
Change in warrant liabilities | 1,119 | — | 722 | — | ||||||||||||
Interest expense | (6,430 | ) | (6,559 | ) | (20,059 | ) | (20,292 | ) | ||||||||
Loss (gain) on foreign currency transactions | 724 | 357 | 6 | (44 | ) | |||||||||||
Other income (expense) | 83 | (12 | ) | 282 | 104 | |||||||||||
Total other expense | (4,504 | ) | (6,214 | ) | (19,049 | ) | (20,232 | ) | ||||||||
Income before income taxes | 6,124 | 1,778 | 23,344 | 15,603 | ||||||||||||
Income tax expense | 1,777 | 1,002 | 8,747 | 6,728 | ||||||||||||
Net income | $ | 4,347 | $ | 776 | $ | 14,597 | $ | 8,875 | ||||||||
Other comprehensive income: | ||||||||||||||||
Foreign currency translation adjustments | (805 | ) | 33 | (389 | ) | 158 | ||||||||||
Comprehensive income | $ | 3,542 | $ | 809 | $ | 14,208 | $ | 9,033 | ||||||||
NCP-ATK Holdings, Inc. and Subsidiaries |
||||||||||||||||
(dba Atkins Nutritionals) | ||||||||||||||||
Net Income to Adjusted EBITDA Reconciliation | ||||||||||||||||
(Unaudited) | ||||||||||||||||
13-Weeks Ended | 39-Weeks Ended | |||||||||||||||
27-May-17 | 28-May-16 | 27-May-17 | 28-May-16 | |||||||||||||
Net Income (As reported in the Q3 10Q) | $ | 4.3 | $ | 0.8 | $ | 14.6 | $ | 8.9 | ||||||||
Interest expense | $ | 6.4 | $ | 6.6 | $ | 20.1 | $ | 20.3 | ||||||||
Income tax expense | 1.8 | 1.0 | 8.7 | 6.7 | ||||||||||||
Depreciation and amortization | 2.5 | 2.5 | 7.4 | 7.7 | ||||||||||||
Stock Based Compensation | (0.3 | ) | 0.5 | 1.1 | 1.5 | |||||||||||
Management Fees (1) | 0.4 | 0.7 | 1.4 | 1.4 | ||||||||||||
Restructuring Charges (2) | 0.0 | 0.2 | 0.1 | 0.7 | ||||||||||||
Transaction Fees/IPO Readiness (One time in nature) | (0.2 | ) | 0.2 | 0.4 | 0.5 | |||||||||||
Legal Costs (One time in nature) | 0.2 | - | 0.6 | 0.0 | ||||||||||||
Frozen Licensing Media (One time in nature) | 0.5 | - | 0.8 | 0.0 | ||||||||||||
Other Exp (3) | (0.8 | ) | (0.4 | ) | (0.1 | ) | (0.0 | ) | ||||||||
Adjusted EBITDA (As defined in the Q3 10Q) | $ | 14.8 | $ | 12.1 | $ | 55.1 | $ | 47.7 | ||||||||
Note: Dollars in millions.
(1) Historical management fees paid to selling shareholders.
(2) One-time costs of restructuring activities
(3) Other charges consist principally of exchange impact of foreign currency transactions as well as minor impacts of channel inventory returns.
NCP-ATK Holdings, Inc. and Subsidiaries | ||||||||||||||
(dba Atkins Nutritionals) | ||||||||||||||
Net Sales to Pro Forma Adjusted Net Sales Reconciliation | ||||||||||||||
(Unaudited) | ||||||||||||||
13-Weeks Ended | 39-Weeks Ended | |||||||||||||
27-May-17 | 28-May-16 | 27-May-17 | 28-May-16 | |||||||||||
Net Sales (As defined in the Q3 10Q) | $ | 96.5 | $ | 104.6 | $ | 298.6 | $ | 324.4 | ||||||
Removal of Frozen Meals related Net Sales | $ | - | $ | (15.8 | ) | $ | - | $ | (46.8 | ) | ||||
Licensing Income Adjustment | - | 1.0 | - | 3.0 | ||||||||||
Net Frozen Meals Licensing Adjustment | - | (14.8 | ) | - | (43.8 | ) | ||||||||
Atkins' Pro forma Adjusted Net Sales | $ | 96.5 | $ | 89.8 | $ | 298.6 | $ | 280.6 | ||||||
Adjusted EBITDA (As defined in the Q3 10Q) | $ | 14.8 | $ | 12.1 | $ | 55.1 | $ | 47.7 | ||||||
Removal of Frozen Meals related EBITDA | $ | - | $ | (0.8 | ) | $ | - | $ | (3.3 | ) | ||||
Licensing Income Adjustment | - | 1.0 | - | 3.0 | ||||||||||
Net Frozen Meals Licensing Adjustment | - | 0.2 | - | (0.3 | ) | |||||||||
Atkins' Pro forma Adjusted EBITDA | $ | 14.8 | $ | 12.3 | $ | 55.1 | $ | 47.4 | ||||||
Note: Dollars in millions. Financial metrics do not include the impact of purchase accounting or other impacts from the consummation of this transaction.
Investor ContactsKatie Turner /Rachel Perkins ICR 646-277-1228 Katie.turner@icrinc.comRachel.perkins@icrinc.com